FDA Panel Votes In Favor of Replimune’s Melanoma Treatment - WSJ
Source:The Wall Street Journal
Independent experts voted 10-3 despite regulators’ concern about the design of the company’s pivotal cancer trial
Related Articles
'Bring 'em on': Delta wants United's crown over the Pacific, too - CNBC
Delta’s president, Peter Carter, told CNBC that the carrier wants to take United on over the …
Intel Stock Drops as Elon Musk Signals Setback for the Chip Maker - Barron's
Intel stock takes a hit after SpaceX and Tesla CEO Elon Musk signals rival Taiwan Semi may muscle …
FedEx Freight Completes Spinoff, Joins S&P 500, Dow Jones Transports Indexes - Investor's Business Daily
FedEx completes spinoff of its FedEx Freight business. Shares join the S&P 500, Dow Jones …
Electric air taxis are finally ready for takeoff - Fortune
A new breed of aircraft—half-helicopter, half-drone—begin real world tests across the U.S. this …